Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 17/20 | 0.54 |
| ▸ | MMP2 | P08253 | 13/20 | 0.54 |
| ▸ | MMP14 | P50281 | 7/20 | 0.54 |
| ▸ | MMP13 | P45452 | 5/20 | 0.50 |
| ▸ | MMP3 | P08254 | 5/20 | 0.50 |
| ▸ | MMP1 | P03956 | 8/20 | 0.49 |
| ▸ | MMP8 | P22894 | 5/20 | 0.48 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.48 |
| ▸ | MMP7 | P09237 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3176978 | 0.94 | FFAR4 (0.49) | MMP9MMP2MMP14MMP1 | |
| SCHEMBL14875138 | 0.92 | FFAR4 (0.47) | MMP9MMP2MMP14MMP1 | |
| Hydrochloric Acid SCHEMBL4007768 | 0.92 | FFAR4 (0.47) | MMP9MMP2MMP14MMP1 | |
| SCHEMBL9779140 | 0.85 | MMP9 (0.56) | MMP9MMP2MMP14MMP13MMP3 | |
| SCHEMBL6090901 | 0.84 | ALDH1A1 (0.58) | — | |
| SCHEMBL9249636 | 0.84 | ALDH1A1 (0.58) | — | |
| SCHEMBL28521152 | 0.82 | ALDH1A1 (0.56) | — | |
| SCHEMBL3310741 | 0.81 | MMP9 (0.54) | MMP9MMP2MMP14MMP13MMP3 | |
| SCHEMBL6925883 | 0.81 | PTGS2 (0.60) | MMP9MMP2MMP14MMP13MMP3 | |
| SCHEMBL30868599 | 0.81 | CA1 (0.50) | MMP9MMP2MMP14MMP13MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101035764-A | 4-trifluoromethoxy phenoxy benzene-4' -sulfonic acid, preparation method and application thereof in medicine | SANOFI AVENTIS DEUTSCHLAND (DE) | 2007-09-12 | — | — | CN | disclosed |
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) | 2007-07-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070155778-A1 | 4-Trifluoromethoxyphenoxybenzol-4-Sulfonic Acids, Method For The Production And Use Thereof In Medicaments | CYP4X1, AFF1, BPGM | MMP9 3653/4885MMP2 2875/4885MMP14 4151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.